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aminin-1 is essential for early embryonic basement
membrane assembly and differentiation. Several steps
can be distinguished, i.e., the expression of laminin
and companion matrix components, their accumulation on
the cell surface and assembly into basement membrane
between endoderm and inner cell mass, and the ensuing
differentiation of epiblast. In this study, we used differentiating
embryoid bodies derived from mouse embryonic stem cells
 
null for 
 
 
 
1-laminin, 
 
 
 
1-integrin and 
 
 
 
/
 
 
 
-dystroglycan to
dissect the contributions of laminin domains and interacting
receptors to this process. We found that (a) laminin enables
 
 
 
1-integrin–null embryoid bodies to assemble basement
L
 
membrane and achieve epiblast with 
 
 
 
1-integrin enabling
 
expression of the laminin 
 
 
 
1 subunit; (b) basement membrane
assembly and differentiation require laminin polymerization
in conjunction with cell anchorage, the latter critically de-
pendent upon a heparin-binding locus within LG module-4;
(c) dystroglycan is not uniquely required for basement
membrane assembly or initial differentiation; (d) dystroglycan
and integrin cooperate to sustain survival of the epiblast and
regulate laminin expression; and (e) laminin, acting via
 
 
 
1-integrin through LG1–3 and requiring polymerization,
can regulate dystroglycan expression.
 
Introduction
 
Basement membranes are extracellular matrices (ECMs)*
that affect the survival and differentiation of adherent cells.
Regulation of their assembly plays a crucial role during develop-
ment, and laminins are essential for this process (Colognato
and Yurchenco, 2000). Initiation of basement membrane in
a tissue requires synthesis of 
 
 
 
, 
 
 
 
, and 
 
 
 
 laminin subunits
and heterotrimer formation (Yurchenco et al., 1997). Once
secreted, laminin engages the cell surface through several
receptors, notably cognate integrins, 
 
 
 
/
 
 
 
-dystroglycan, and
syndecans (Oh et al., 1997; Edwards et al., 1998; James et al.,
2000), and self-assembles into a matrix polymer (Yurchenco,
1994). Although 
 
 
 
1-integrin and dystroglycan have each
been proposed to be key mediators of basement membrane
formation (Henry and Campbell, 1998, Klass et al., 2000;
Lohikangas et al., 2001), several exceptions suggest that such
mediation is not tightly coupled to assembly (Cote et al.,
1999; Feltri et al., 2002) and may be indirect. One possibility
is that these receptors regulate the synthesis or turnover of
basement membrane components rather than the assembly
process itself. To distinguish these contributions and to dissect
functions of laminin, its domains, and interacting receptors,
we undertook an analysis of cellular differentiation in embryoid
bodies (EBs) derived from mouse embryonic stem (ES) cells
that recapitulate crucial events of basement membrane
formation during early gastrulation.
The first basement membranes to form during mouse
embryonic development are those located between visceral
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endoderm and developing epiblast, and underneath the pari-
etal endoderm (Reichert’s membrane), which extends over
the trophectoderm (Leivo et al., 1980). Although primitive
endodermal cell differentiation precedes basement mem-
brane assembly, epiblast differentiation and proamniotic cavi-
tation require and follow it (Murray and Edgar, 2000;
Murray and Edgar, 2001a,b). In this study, we examined
wild-type, 
 
 
 
1-laminin–null, 
 
 
 
1-integrin–null, and dystro-
glycan-null differentiating EBs. We report that the integrin- and
laminin-deficient cells are unable to form basement mem-
branes or undergo epiblast differentiation and cavitation be-
cause, in both states, they fail to express heterotrimeric lami-
nin. Exogenous laminin bypasses the defect in each null
embryoid body, restoring basement membrane along with
epiblast differentiation and cavitation. This activity requires
participation of long arm laminin LG modules that include a
critical heparin-binding sequence as well as polymerization
mediated by the three short arms. Strikingly, neither integrin
nor dystroglycan is uniquely required for basement mem-
brane assembly. Instead, they are necessary for regulation of
their own expression, that of major basement membrane
components, and cell differentiation. Finally, dystroglycan
and integrin promote epiblast survival.
 
Results
 
Laminin-1 rescue of basement membrane and 
differentiation in 
 
 
 
1-integrin–null EBs
 
It has previously been shown that 
 
 
 
1-integrin–null (
 
 
 
/
 
 
 
)
EBs fail to develop basement membranes and that 
 
 
 
1-lami-
nin chain expression is decreased (Aumailley et al., 2000). It
has also been proposed that 
 
 
 
1-integrins are required as re-
ceptors for basement membrane assembly (Raghavan et al.,
2000; Lohikangas et al., 2001). However, given the 
 
 
 
1-
laminin subunit is necessary to assemble a heterotrimeric
laminin (Yurchenco et al., 1997), we considered the possi-
bility that the failure to form a basement membrane and dif-
ferentiate is due to the absence of laminin 
 
 
 
1-chain expres-
sion rather than the receptor-mediated cell surface assembly
process itself. To test this hypothesis, we compared the be-
havior of 
 
 
 
1-integrin–null EBs incubated in the presence of
exogenous laminin-1 with untreated null and wild-type EBs
(Fig. 1 and Table I).
When dispersed wild-type embryonic stem cells are sus-
pended in LIF-free medium for several days, they form EBs
that (a) develop an outer endodermal layer, (b) form a sub-
endodermal basement membrane, and (c) differentiate to
form epiblast and a central proamniotic-like cavity (Cou-
couvanis and Martin, 1995; Murray and Edgar, 2000).
These progressions were observed in wild-type controls with
endoderm appearing at 3–4 d, basement membrane at 4–5 d,
and epiblast at 5–7 d. Although integrin 
 
 
 
1-integrin–null
EBs developed morphological features of endodermal differ-
entiation (a distinct outer layer with flattened cells and/or
cells containing vacuoles), neither basement membrane, epi-
blast, nor central cavity formed. However, when 
 
 
 
1-inte-
grin–null ES cells were incubated with 25 
 
 
 
g/ml laminin-1,
nearly half of the EBs underwent striking morphological and
immuno-histochemical changes (Fig. 1). By phase-contrast
microscopy, these EBs possessed a distinctive second cell
layer consisting of polarized cells in a pseudo-stratified co-
lumnar arrangement and with the innermost aspect facing a
sharply demarcated central cavity (Fig. 1 A). A thin bright
line corresponding to an ECM circumscribed the outermost
edge of this layer. By immunofluorescence microscopy, the
EBs exhibited colocalization of laminin (
 
 
 
1 epitope), type
IV collagen, nidogen, and perlecan in a linear and generally
continuous pattern located between endoderm and epiblast
 
Table I. 
 
Basement membrane formation and epiblast differentiation in wild-type, dystroglycan-null, 
 
 
 
1-laminin–null
 
, 
 
and 
 
 
 
1-integrin–null 
embryoid bodies
EBs Treatment Basement membrane formation Epiblast differentiation Number counted
 
%
 
Nulls
 
Wild-type 72 
 
 
 
 9 64 
 
 
 
 7 145
DG
 
 
 
/
 
 
 
 75 
 
 
 
 4 51 
 
 
 
 6 191
 
 
 
1-Lm
 
 
 
/
 
 
 
0 0 253
 
 
 
1-Lm
 
 
 
/
 
 
 
Laminin-1 57 
 
 
 
 9 34 
 
 
 
 5
 
a
 
150
 
 
 
1-integrin
 
 
 
/
 
 
 
0 0 173
 
 
 
1-integrin
 
 
 
/
 
 
 
Laminin-1 46 
 
 
 
 2 18 
 
 
 
 2
 
a
 
174
 
Isoforms
 
 
 
1-Lm
 
 
 
/
 
 
 
Laminin-1 (
 
 
 
1
 
 
 
1
 
 
 
1) 59 36 150
 
 
 
1-Lm
 
 
 
/
 
 
 
Laminin-2/4 (
 
 
 
2
 
 
 
1
 
 
 
1/
 
 
 
2
 
 
 
2
 
 
 
1) 37 9 35
 
 
 
1-Lm
 
 
 
/
 
 
 
Laminin-4 (
 
 
 
2
 
 
 
2
 
 
 
1) 40 20 40
 
 
 
1-Lm
 
 
 
/
 
 
 
Laminin-5 (
 
 
 
3A
 
 
 
3
 
 
 
2) 0 0 44
 
 
 
1-Lm
 
 
 
/
 
 
 
Laminin-8 (
 
 
 
4
 
 
 
1
 
 
 
1) 0 0 42
 
Modified laminin-1 and fragments
 
 
 
1-Lm
 
 
 
/
 
 
 
AEBSF–laminin-1 0 0 39
 
 
 
1-Lm
 
 
 
/
 
 
 
Laminin-1 
 
 
 
 E1’ 0 0 39
 
 
 
1-Lm
 
 
 
/
 
 
 
Laminin-1 
 
 
 
 AEBSF-E1’ 53 11 66
 
 
 
1-Lm
 
 
 
/
 
 
 
Laminin-1 
 
 
 
 E4 2 0 43
 
 
 
1-Lm
 
 
 
/
 
 
 
Laminin-1 
 
 
 
 E3 0 0 58
 
 
 
1-Lm
 
 
 
/
 
 
 
Laminin-1 
 
 
 
 E8 39 16 44
EB, embryoid body.
 
a
 
P
 
   0.001 versus wild type. Data were obtained from four to six separate experiments for each group and expressed as mean   SE. Embryonic basement membrane assembly | Li et al. 1281
(Fig. 1 B). We examined the survivability of the laminin-
induced EBs and found, using TUNEL staining, that an in-
crease in segmental cell layer apoptosis occurred selectively
in the epiblast layer (Fig. 1, C and D); however, the layer re-
mained intact even after 11 d.
Wild-type and  1-integrin–null EBs treated with exoge-
nous laminin-1 were examined for  1- and  6-integrin ex-
pression (Fig. 1, E and F). These integrin chains were local-
ized in differentiated wild-type EBs in the epiblast and in the
basement membrane zone. In contrast, the integrin-null
EBs, regardless of treatment, failed to express and accumu-
late  6-integrin.  1-integrin levels in dystroglycan-null EBs
were similar to those detected by immunoblotting in the
wild-type state (and were absent in the integrin-null state),
suggesting that integrin does not compensate for loss of dys-
troglycan by up-regulation.
Contributions of laminin polymerization and LG modules
Incubation of  1-laminin–null EBs with exogenous lami-
nin-1 results in basement membrane formation, epiblast dif-
ferentiation, and cavitation (Murray and Edgar, 2000), pro-
viding a basis to analyze laminin domain contributions. We
evaluated (a) the three short arms that mediate laminin poly-
merization as well as  1 1,   2 1 integrin, and heparin
binding and (b) G-domain that mediates  6 1,  7 1 inte-
grin-, heparin/heparan sulfate–, and  -dystroglycan binding
(Colognato and Yurchenco, 2000). To assess polymerization
and discriminate it from other short arm functions, we de-
termined the ability of nonpolymerizing laminin-1, pre-
pared by treatment with the selective polymer-inactivating
agent aminoethyl benzene sulfonyl fluoride (AEBSF; Colog-
nato et al., 1999), to assemble a basement membrane in  1-
laminin–null EBs (Fig. 2 and Table I) and evaluated the ac-
Figure 1. Laminin induction of basement membrane and epiblast in  1-integrin–null EBs. Wild-type and  1-integrin–null ES cells were 
grown in suspension for 7 d, the latter maintained alone or in the presence of laminin-1 (25  g/ml). (A) Phase micrographs (left) and methylene 
blue-stained sections (right) of wild-type (top), untreated (middle) and laminin-1–treated (bottom)  1-integrin–null EBs. (B) Immunofluorescence 
micrographs of consecutive sections of the above EBs stained with DAPI (nuclei, blue) and antibody to laminin- 1 (Lm), type IV collagen 
(Col-IV), perlecan (Perl) and nidogen (Nd). (C and D)  1-integrin–null EBs were treated with 25  g/ml laminin-1 and cultured for 7–11 d. 
TUNEL (green) and DAPI (blue) costaining revealed developing segmental (arrow) apoptosis (plot was calculated after subtracting EBs with 
full-thickness segmental apoptosis from the total). (E) Immunoblot detection of the  1-integrin subunit in wild-type (lane 1),  1-integrin–null 
(lane 2), dystroglycan-null (lane 3), and  1-laminin–null (lane 4) EBs. (F) Immunofluorescence micrographs showing  1-integrin (first frame), 
 6-integrin (third frame), and  1-laminin (second and fourth frames) of wild-type (top) and laminin-treated  1-integrin–null EBs (bottom).1282 The Journal of Cell Biology | Volume 157, Number 7, 2002
tivity of laminin-1 maintained in the presence of fragments
that selectively inhibit polymerization through either the
 1/ 1 (E1 , AEBSF-treated E1  as noninhibiting control)
or the  1 (E4) short arms. Neither a basement membrane
immunostaining pattern of laminin and type IV collagen
nor epiblast formation was detected after inhibition of lami-
nin polymerization, regardless of reagent used. This inhibi-
tion was considered specific because the only activity of E4 is
polymerization inhibition, and the cell adhesion, heparin-
binding, and nidogen-binding properties of laminin and E1 
are not found affected by AEBSF treatment (Colognato et
al., 1999; unpublished data).
To analyze laminin long arm contributions, we deter-
mined the ability of polymerizing-laminin that lacks the
coiled-coil and G-domains (fragment C1–4) to induce ma-
trix assembly, and evaluated the potential of fragments E3
(containing LG module 4, a ligand for heparin, sulfatide,
and dystroglycan) and E8 (LG modules 1–3, ligand for  6
and  7 integrins) to inhibit laminin-1 induction of base-
ment membrane. C1–4 treatment of  1-laminin–null EBs
for 7 d did not result in the formation of a basement mem-
brane or in epiblast differentiation. When fragment E3 was
incubated in molar excess with intact laminin-1, neither
basement membrane nor epiblast differentiation was de-
tected (Fig. 2, rows 5 and 6). In contrast, fragment E8, when
similarly incubated with laminin-1, did not prevent laminin
rescue of assembly. We concluded that one or two of the LG
modules contained within E3 (LG4–5) were required for
basement membrane.
After treatment with either laminin-4 or laminin-2/4,
laminin, type IV collagen, nidogen, and perlecan were de-
tected in a subendodermal linear pattern accompanied by
epiblast differentiation and cavitation (Table I). In contrast,
laminin-8 ( 4 1 1) failed to induce basement membrane–
type immunostaining, epiblast differentiation, or central
cavitation. Laminin-5 ( 3A 3 2) adhered to the outer sur-
face of the EBs (image not depicted); however, laminin-5,
 1-laminin,  3-laminin, and nidogen did not accumulate
within the basement membrane zone. Although a weaker
and discontinuous linear subendodermal pattern of type IV
collagen and perlecan was noted, no ECM was detected by
electron microscopy. Thus, of the laminins tested, only  1-
and  2-laminins, both polymerizing laminins, were capable
of inducing basement membrane.
Site of activity in an LG module
To determine whether heparin/dystroglycan binding within
LG module 4 is required for basement membrane, we inac-
tivated the KRK (residues 2791–2793) sequence common
to both by alanine substitution (Andac et al., 1999) in re-
combinant LG4–5 and determined its ability to block lami-
nin-1 rescue of Lm- 1–null EBs (Fig. 3). The mutant
LG4–5 showed substantially reduced binding by heparin
affinity chromatography (Fig. 3 A), eluting at 0.16 M NaCl
compared with 0.26 M for wild-type protein. In contrast to
its recombinant control, the KRK mutant protein was
largely unable to block laminin rescue of the Lm- 1–null
phenotype (Fig. 3, B and C). In keeping with this result,
0.1 mg/ml heparin completely prevented laminin-1 induc-
tion of basement membrane. We concluded that this partic-
ular surface-exposed triplet basic sequence (Fig. 3 D) plays a
critical role in basement membrane assembly, likely con-
tributing to anchorage.
Mesodermal differentiation
Because laminin treatment of  1-integrin and  1-laminin–
null EBs enabled differentiation of epiblast morphology,
we asked whether the “rescue” also initiated mesodermal
differentiation. To address this, we examined the transcrip-
tional expression of low molecular weight neurofilament
(NFL; expressed in ectodermal derivatives), BMP-4 (ES
cells and mesoderm), brachyury (mesodermal T transcrip-
tional factor), and  -globulin (mesoderm) by semi-quanti-
tative reverse transcription (RT)–PCR (Fig. 4). All markers
were detected in wild-type EBs. By 7 d of culturing, NFL
and BMP-4 were detected in both  1-integrin–null and
laminin- 1–null EBs if treated with laminin-1, but not if
untreated. Brachyury and  -globulin were detected in  1-
Figure 2. Laminin domains contributing to basement membrane 
assembly.  1-Laminin–null EBs were cultured for 7 d without laminin 
as a control (Ctrl), or with either laminin-1 (Lm1, 25  g/ml), non-
polymerizing laminin-1 (A-Lm1, AEBSF-treated, 25  g/ml), or fragment 
C1–4 (25  g/ml) as shown. In addition, EBs were treated with 
laminin-1 mixed with an  50-fold molar excess of polymer-inhibiting 
fragment E1’, noninhibiting AEBSF-E1’ control (A-E1’), polymer-
inhibiting fragment E4,  6 1-integrin–binding fragment E8, or 
dystroglycan/heparin/sulfatide-binding fragment E3 (fragment map 
shown in Fig. 10). Embryonic basement membrane assembly | Li et al. 1283
laminin–null EBs treated with laminin, but not  1-inte-
grin–null EBs treated with laminin. By week 2 of cultur-
ing, brachyury was detected in the  1-integrin–null EBs
treated with laminin as well (unpublished data). These
data reflect a delay of mesodermal differentiation in the in-
tegrin-deficient EBs.
Contribution of dystroglycan to basement membrane 
assembly and epiblast survival
Given that a site in LG4 mediating both heparin- and dys-
troglycan binding is essential for basement membrane as-
sembly, we asked whether dystroglycan was responsible for
Figure 3. Heparin-binding site in LG4 is required 
by laminin mediation of basement membrane 
assembly in laminin  1-null EBs. (A) Elution of 
recombinant wild-type and KRK→AAA mutant 
recombinant LG4–5 from a heparin 5PW column 
with a NaCl gradient. (B) Immunofluorescence 
(laminin  1, type IV collagen) micrographs of 
 1-laminin–null EBs treated with either laminin-1 
in the presence of a 20-fold molar excess of 
wild-type or mutated LG4–5. (C) Quantitation of 
degree of basement membrane formation. 
(D) Space-filling model of Lm- 1 LG4 KRK sequence 
(blue) superimposed upon the crystal structure of 
 2-LG4 determined from coordinates submitted to 
the Brookhaven protein database.
Figure 4. Expression of differentiation markers.  1-integrin–null 
( 1 int / ) and  1-laminin–null (Lm  1 / ) ES cells untreated or 
treated with laminin-1 (Lm1, 25  g/ml) and wild-type ES cells were 
cultured in suspension for 7 d. Total RNA was isolated and subjected to 
semi-quantitative RT-PCR analysis for epiblast (low molecular 
weight NFL) and mesoderm (brachyury, T(B), and  -globin) marker 
expression. HPRT was used as normalizing control.
this interaction. We found that by 5 d of culturing, most
dystroglycan-null EBs possessed linear subendodermal colo-
calized distributions of laminin, type IV collagen, nidogen,
and perlecan (Fig. 5 and Table I), i.e., characteristics of a
basement membrane later confirmed by electron micros-
copy. The spontaneous formation of these ECMs (i.e., with-
out exogenous laminin) was accompanied by epiblast differ-
entiation and cavitation. These results were consistent with
the mouse knockout phenotype in which epiblast-associated
basement membranes were detected (Williamson et al.,
1997), and the data suggest that a heparan sulfate proteogly-
can such as a member of the syndecan family (and/or possi-
bly sulfatide), rather than dystroglycan, mediates an essential
laminin–LG-4 interaction.
The epiblast cells that developed in dystroglycan-null
EBs were clearly polarized but tended to be shorter in
length. By 7 d, many EBs were noted to possess unusually
thick basement membranes by light microscopy (Fig. 6).
By 9 d, the epiblast layer was found to have partially or
completely degenerated in most EBs, leaving behind EBs
consisting only of an outer endoderm layer resting on an
otherwise acellular basement membrane with a hollow cav-
ity. A progression of epiblast loss could be followed from 7
to 9 d. This ectodermal degeneration, in which remaining
cells had smaller and denser nuclei, suggested that the epi-
blast cells were undergoing apoptosis. TUNEL staining
and coincident nuclear DAPI staining confirmed the de-
velopment of apoptosis in dystroglycan-null EBs by 7 d,
culminating in the loss of the layer in most EBs by 9 d.
The increase in TUNEL staining could be seen in associa-
tion with both thin and thick basement membranes.
Basement membrane zone ultrastructure
Thin sections of wild-type,  1-integrin–null,  1-laminin–
null, and dystroglycan-null EBs were examined by electron1284 The Journal of Cell Biology | Volume 157, Number 7, 2002
(ICM) or epiblast. Wild-type basement membranes located
between endoderm and epiblast layer ranged in thickness
from  0.25 to  1.5  m (Fig. 7 B) and often had a layered
appearance, particularly in cell-adjacent zones. Untreated
 1-integrin–null and  1-laminin–null EBs lacked a base-
ment membrane, even by 9 d of culturing (Fig. 7, A and
D). The endoderm layer instead showed direct contact with
underlying cells, occasionally interrupted by a small, appar-
ently empty space. In contrast, a distinct basement mem-
brane was observed after treatment of  1-integrin–null
(Fig. 7 C) or  1-laminin–null EBs (Fig. 7 G) with exoge-
nous laminin. The morphology was similar to that observed
in the wild-type state. The epiblast layer contained adjacent
elongated cells with a cytoplasm containing minimal RER
and a finely granular cytoplasm. Junctional complexes were
noted between cells (images not shown). The epiblast fea-
tures were the same as observed in differentiated wild-type
EBs. Dystroglycan-null EBs also developed prominent
basement membranes ( 10  m; Fig. 7, H and I) that sub-
stantially separated endodermal layers from epiblast layers.
The fraction of the thick basement membranes was noted
to increase with culturing extending out to 7 d. The RER of
the dystroglycan-null EBs was noted to be more prominent
than those of wild-type EBs, containing more RER cister-
nae that were especially dilated in dystroglycan-null EBs
with thick basement membranes.
 1-Laminin–null EBs treated with laminin-5 (Fig. 7 E),
nonpolymerizing laminin-1 (Fig. 7 F), or laminin-1 plus E1 
did not contain a recognizable basement membrane at the
ultrastructural level. The endoderm was located either in
close apposition to the ICM or separated by very narrow and
largely empty clefts. Scattered amorphous deposits, possibly
corresponding to ECM protein, were sometimes detected
within the clefts. Thus, although type IV collagen immuno-
staining was elevated over null controls, after treatment with
laminin-5 and (to a lesser extent) nonpolymerizing laminin,
no organized ECM was detected (Fig. 7 E).
Figure 6. Development of epiblast apoptosis and 
basement membrane thickening in dystroglycan-null 
EBs. Untreated dystroglycan-null EBs and wild-type 
controls were cultured for 5–9 d. Thick basement 
membranes developed in dystroglycan-null EBs as 
seen both in immunofluorescence micrographs 
(laminin- 1 epitope in red) and the thick section. 
An epiblast layer is seen in both forms of EBs. By 
9 d, epiblast layer degeneration is observed. 
TUNEL (green) and DAPI (blue) costaining reveals 
apoptosis in wild-type and dystroglycan-null cells 
over time. Epiblast apoptosis was prominent in 
the dystroglycan-null, but not the wild-type, EBs, 
and was augmented over time. The EBs with partial 
and complete degeneration and loss of the epiblast 
layer were subtracted from the total EBs counted. 
The plot shows the percentage of remaining EBs 
with surviving epiblast layers.
microscopy (Fig. 7). The overlying endoderm in all four
types of EBs possessed an increase in prominence of RER
and mitochondria compared with adjacent inner cell mass
Figure 5. Basement membranes assemble in dystroglycan-null 
EBs. Dystroglycan-null ES cells, suspended at the first passage from 
feeder cell layers, were allowed to form EBs for 5 d in the absence 
of any treatment. (A) Phase micrograph and (B) methylene 
blue–stained section show epiblast differentiation, cavitation, and 
thin basement membranelike structures (arrows). (C) EBs, visualized 
by immunofluorescence, reveal a subendodermal basement 
membrane pattern costaining with antibodies for  1-laminin, type 
IV collagen, perlecan, and nidogen. Embryonic basement membrane assembly | Li et al. 1285
Dystroglycan expression
Examination of  -dystroglycan immunofluorescence of
early and differentiated wild-type EBs revealed that  -dys-
troglycan was initially diffusely distributed throughout the
ICM in a pericellular pattern, but then redistributed to the
basement membrane zone after basement membrane forma-
tion (Fig. 8). The latter pattern appeared to be largely con-
fined to the epiblast aspect of the zone (this was particularly
evident if the epiblast layer became detached from base-
ment membrane during sectioning). No staining, as ex-
pected, was observed in dystroglycan-null EBs. The pericel-
lular dystroglycan immunostaining intensity was greater in
 1-integrin and  1-laminin–null EBs compared with wild-
type EBs (Fig. 8 A). After laminin-1 treatment of the inte-
grin-null EBs, dystroglycan became redistributed to the
basement membrane zone, whereas the staining intensity
remained high. Laminin-1 treatment of the  1-laminin–
null EBs similarly caused redistribution of dystroglycan to
the basement membrane zone; however, the staining inten-
sity was now decreased.
The relative abundance of  -dystroglycan present in wild-
type and null EBs was measured in immunoblots of deter-
gent extracts (Fig. 8 B) in which equal amounts of total pro-
tein were loaded in each lane. A relatively small amount of
dystroglycan was detected in wild-type and no dystroglycan
was detected in the dystroglycan-null EBs as expected. The
dystroglycan level was severalfold higher compared with
wild-type EBs in both the untreated and laminin-treated
 1-integrin–null EBs, consistent with the immunofluores-
cence data. We concluded that  1-integrin and laminin are
Figure 7. Ultrastructure of EBs. Wild-type (R1),  1-laminin–null,  1-integrin–null, and dystroglycan-null EBs, untreated and laminin-treated, 
were examined by electron microscopy after incubation in suspension culture for 5–7 d. The regions containing junctions of the endodermal 
layer and ICM or epiblast layer are shown. (A)  1-Integrin–null embryoid body, 7 d. Endoderm (above arrows) was present; however, neither 
basement membrane nor epiblast differentiation is present. Arrows indicate endodermal/ICM cell boundary and n indicates nucleus. 
(B) Wild-type embryoid body (7 d) reveals basement membrane between endoderm and epiblast (between arrows). (C)  1-Integrin–null 
embryoid body treated with laminin-1 (25  g/ml, 7 d). Basement membrane (arrows) is located between endoderm and epiblast layers. Scattered 
small clefts (arrowhead) located between cell and matrix were present more frequently in these EBs compared with wild-type. (D)  1-Laminin–null 
EB, 7 d. No basement membrane was detected at the endoderm/ICM cell boundary (arrows). (E)  1-Laminin–null EB treated with laminin-5 (7 d). 
Endodermal differentiation in the absence of basement membrane was seen. Endodermal/ICM interface indicated by arrows. (F)  1-Laminin–null 
EBs treated with nonpolymerizing laminin-1 (25  g/ml, 7 d). No basement membrane or epiblast differentiation was detected. (G)  1-Laminin–null 
EBs treated with (polymerizing) laminin-1 (25  g/ml, 7 d). Note prominent basement membrane between endoderm and epiblast layers 
(arrows). (H and I) Dystroglycan-null EBs, 5 d. Note typical basement membrane (H) lying between endoderm and epiblast cell layers. The 
RER (asterisk) of the endoderm is dilated.1286 The Journal of Cell Biology | Volume 157, Number 7, 2002
both required to maintain dystroglycan at a normal level.
Therefore, we asked whether this protein expression was di-
rectly regulated by laminin-1, a potential ligand.  1-Lami-
nin–null EBs were incubated with laminin-1 in the presence
of excess E8 fragment that contains the  6 1 integrin-bind-
ing site (Fig. 8 C). E8 treatment reversed the effect of lami-
nin-1 to down-regulate  -dystroglycan in  1-laminin–null
EBs. In contrast, AEBSF-E1  that possesses the binding ac-
tivities for  1 1 and  2 1 integrins, did not prevent the
laminin-1-mediated decrease in dystroglycan expression. As
shown earlier, neither of these two fragments inhibits base-
ment membrane assembly (Fig. 2). The results support the
hypothesis that the specific ligand-mediating dystroglycan
regulation is a property of the E8 region of laminin and
likely lies within laminin LG1–3.
Alterations of basement membrane component 
synthesis and accumulation
The expression and accumulation of basement membrane
components were evaluated (Fig. 9). Loads of all fractions
for analysis were normalized to total protein present in each
EB extract. Conditioned medium protein contained the
ECM components that accumulated into a final “pool” in
transit from the EB, resulting either from turnover or cell
death. The EB cell lysate, containing  10% of total endog-
enous basement membrane proteins present in each culture,
represented the material that accumulated in basement
membrane and cell (most epitopes were present within the
basement membrane zone as determined by microscopy).
When EB extracts or conditioned media were immunopre-
cipitated with laminin  1,  1, or  1 chain–specific anti-
Figure 8. Dystroglycan distribution and expression. (A) Dystroglycan 
distribution of wild-type (first column), dystroglycan-null (second 
column), both laminin-untreated (third column) and treated (fourth 
column)  1-integrin–null EBs, and laminin-untreated (fifth column) 
and treated (sixth column)  1-laminin–null EBs. (B) Wild-type EBs, 
dystroglycan-null (DG  / ) EBs,  1-integrin–null ( 1 / ) EBs 
untreated, laminin-1–treated (Lm1), or nonpolymerizing laminin 
treated (A-Lm1), and  1-laminin–null EBs, untreated, laminin-1–
treated, or nonpolymerizing laminin treated EBs cultured for 7 d 
were detergent-extracted, normalized for total protein, analyzed by 
reducing SDS-PAGE, and transferred onto membranes that were 
incubated with  -dystroglycan–specific mAb with the bands 
detected with sheep anti–mouse IgG-HRP. Inset shows heavier sample 
load for wild-type and dystroglycan-null EBs. (C) Using the above 
conditions, E8 and AEBSF-treated E1’ (each an integrin ligand) were 
incubated in 50-fold molar excess with laminin-1 followed by 
immunoblotting to detect  -dystroglycan subunit expression.
Figure 9. Expression and accumulation of basement membrane 
components. Conditioned media (10 ml from the last 2 d) and EBs 
were collected from cultures of wild-type,  1-integrin–null, 
 1-laminin–null, and dystroglycan-null ES cells maintained for 7 d. 
The cell pellets were extracted with 0.5 ml of lysis buffer, 0.5 ml 
conditioned medium, or 0.15 ml EB lysates were incubated with 
antibody specific for the laminin- 1 (anti-RG50),  1 (anti-E4), or  1 
(rat anti–mouse  1 chain mAb), and then pulled down with protein 
A or protein G coupled to agarose beads (immunoprecipitation 
[IP]). Alternatively, the extract or medium fraction was analyzed
directly with EHS laminin-1-specific pAb in immunoblots (IB). 
(A) Laminin. Medium (IP/IB) and embryoid body cell pellet (IB or IP/IB). 
Samples correspond to EBs prepared from wild-type (lane 1),
 1-laminin–null (lane 2),  1-integrin–null (lane 3), and dystroglycan-
null (lane 4) ES cells, shown in comparison to purified EHS laminin-1 
(lane 5). (B) Nidogen. Media and extracted EB pellets were analyzed 
in immunoprecipitates/immunoblots with specific antibody for 
nidogen as follows: wild-type (lane 1),  1-laminin–null (lane 2), 
 1-integrin–null (lane 3), dystroglycan-null (lane 4), and nidogen 
standard (lane 5). (C) Type IV collagen-specific antibody was used 
to immunoprecipitate the collagen from media and EB fractions 
followed by reducing SDS-PAGE and Coomassie blue staining. Type 
IV collagen immunoprecipitated from wild-type conditioned medium 
or EBs could be digested with bacterial collagenase (lane 5). Embryonic basement membrane assembly | Li et al. 1287
bodies, no heterotrimeric laminin-1 was detected in the  1-
laminin–null state. In addition to the expected absent  1
chain, the  1 chain was absent, possibly a consequence of
degradation. In  1-integrin–null EBs, laminin chains were
not detected with EHS-laminin–specific antibody after pre-
cipitation with  1 subunit–specific antibody from either
medium or cell lysates. However, immunoprecipitation of
 1-integrin–null cell extracts with either laminin  1– or
laminin  1–specific antibody revealed an incompletely re-
solved   /  doublet. We concluded that these chains,
present in low amount, are present within the endodermal
cell cytoplasm because no basement membrane formed in
these EBs, whereas weak diffuse intracellular endodermal
staining could be detected. These data support and extend
the conclusions of Aumailley et al. (2000) but do not sup-
port those of Lohikangas et al. (2001) i.e., laminin  1 ex-
pression is selectively absent in  1-integrin–null EBs. It fol-
lows that the block to assembly is due to the laminin
expression defect rather than to a role of  1-integrin in the
polymerization of laminin or in its cell surface receptor–
mediated assembly.
In contrast to the wild-type state, both cell and media
fractions obtained from dystroglycan-null EBs contained
elevated levels of laminin-1, type IV collagen, and ni-
dogen. This overexpression of components correlates with
the appearance of dilated ER in the endodermal cells, the
principle source of basement membrane proteins. Endo-
dermal ECM overexpression may explain the unusual
thickness that develops in the dystroglycan-null basement
membranes. The absence of basement membrane forma-
tion in the  1-integrin–null and  1-laminin–null EBs was
accompanied by the presence of only trace amounts of ni-
dogen and type IV collagen in the EB fractions. However,
lack of a basement membrane was not accompanied by a
substantial decrease of either nidogen or type IV collagen
expression, as these proteins still accumulated in condi-
tioned media. Thus, we concluded that the absence of
laminin polymer accumulation between endoderm and
ICM results in a failure to sequester nidogen and collagen
within the basement membrane zone, even though these
components continue to be synthesized and secreted.
Discussion
Embryonic basement membrane assembly, a process in
which soluble extracellular monomers form a supramolecu-
lar architecture in association with a specific cell surface, re-
quired that laminin polymerize and interact with the surface
through its G-domain, critically depending upon the hep-
arin-binding KRK sequence within LG4 (Fig. 10). On the
other hand, in the presence of laminin-1, neither  1-inte-
grin nor dystroglycan was uniquely needed for this assembly
or for the subsequent differentiation of the epiblast. Instead,
we found that  1-integrin and dystroglycan acted upstream
and downstream of assembly, mediating laminin  1–chain
expression and affecting the regulation of dystroglycan and
other basement membrane components.
 1-Integrin functions
The ability of exogenous laminin-1 to rescue the integrin-
defect with restoration of basement membrane formation
and epiblast development indicates that the early differentia-
tion block in  1-integrin–null EBs is due to the failure of
laminin  1–chain expression (either transcriptional or post-
transcriptional) and is not at the level of basement mem-
brane anchorage and assembly. This contribution may be
specific for laminin- 1 because similar regulation has not
been observed for Schwann cell basement membranes lack-
ing this integrin subunit (Feltri et al., 2002).  1-Integrin
was not required for the integration of type IV collagen, ni-
dogen, or perlecan into the basement membrane, suggesting
that their incorporation into a laminin scaffold is mediated
either directly through laminin interactions or through
novel cell surface molecules. Furthermore, the data show
that   1-integrin, once the laminin synthesis block is by-
passed, is not required for epiblast differentiation and cavita-
tion, although it is essential for mesodermal differentiation.
Although other  -integrins might compensate for the miss-
ing  1 subunit, there is no obvious candidate. None of the
known laminin-interacting integrins ( 6 and therefore  4)
were detected in  1-integrin–null ES cells and/or EBs.
Although integrin compensation was not detected, dystro-
glycan was substantially overexpressed in  1-integrin–null
EBs. Laminin induced a topographical redistribution of dys-
Figure 10. Model of laminin 
interactions. (a) Laminin-1 and its 
fragments. (b)  1-Integrin initiates 
laminin- 1 expression in endoderm, 
enabling heterotrimer formation and 
secretion. The laminin becomes anchored 
to and concentrated on the endodermal 
(not depicted) and (shown) outer ICM cell 
surfaces largely via LG4–5, accompanied 
by recruitment of  1-integrins and  / -
dystroglycan (DG) that interact with 
LG1–3 and LG4, respectively. Laminin 
polymerizes through its short arms 
creating a multivalent network. The 
ICM, requiring this network, but not 
requiring integrin or dystroglycan, 
becomes polarized and converted to 
epiblast.  6 1-Integrin, interacting with polymerizing laminin through LG1–3, down-regulates dystroglycan (DG), and dystroglycan 
down-regulates basement membrane components. Type IV collagen forms a second network and nidogen and perlecan are incorporated 
into a more stable ECM. Mesodermal differentiation is delayed in the laminin-treated integrin-null EBs.1288 The Journal of Cell Biology | Volume 157, Number 7, 2002
troglycan such that it localized to sites in the basement
membrane zone; however, it did not restore normal dystro-
glycan levels. Dystroglycan was similarly overexpressed in
the   1-laminin–null EBs, suggesting that laminin is re-
quired to maintain normal dystroglycan expression. The hy-
pothesis was supported by the finding that exogenous lami-
nin mediated both the correct basement membrane zone
localization and normalization of dystroglycan expression.
Furthermore, treatment of  1-laminin–null EBs with E8
(ligand for  6 1 integrin) abrogated laminin-mediated dys-
troglycan down-regulation. These data not only show that
dystroglycan expression and localization is regulated by
laminin and  1-integrin, but also suggest that this regula-
tion requires the direct ligation of laminin G-domain within
a polymer to the integrin.
Role of a heparin-binding site in LG4
 6 1,  7 1, and  6 4 integrin–binding sites are located
in LG modules 1–3, whereas heparin/heparan sulfate, sul-
fatide, and  -dystroglycan–binding sites are located within
LG module-4. A third cell-interactive domain, capable of
binding to heparin and  1 1 and  2 1 integrins, and lo-
cated within the LN domain of the  1 subunit (Colognato-
Pyke et al., 1995; Colognato et al., 1997), was not found to
participate in embryonic basement membrane assembly. In
EBs, LG module 4 was found to be required for basement
membrane assembly, which is consistent with the concept
that it provides for the key anchorage to the cell surface. We
examined this further by alanine mutagenesis of an impor-
tant heparin/dystroglycan-binding sequence, EYIKRKAF,
located between inter-  strand loops H and I of LG4 (Tisi
et al., 2000). We found that the mutation, which substan-
tially decreased heparin-binding, inactivated LG4–5 inhibi-
tion of assembly. The possibility that dystroglycan was an
essential receptor for assembly, mediated through this site,
was ruled out because dystroglycan-null EBs spontaneously
formed basement membrane. This in turn suggests that the
critical LG4 interaction is mediated by a heparan sulfate
proteoglycan, or possibly by a sulfatide. However, an impor-
tant remaining question is whether laminin anchorage and
basement membrane assembly can occur in the absence of
both integrin and dystroglycan, requiring only LG4 heparin-
type binding and polymerization. Because integrin and dys-
troglycan may provide some of the anchorage activity them-
selves, it is possible that a minimum of two of the three
binding sites in G-domain are required. Alternatively, the
heparin-site may provide sufficient anchorage in the absence
of either receptor. Resolution of this question will require
further experimentation.
Role of dystroglycan
Our study has shown that dystroglycan is not required for
formation of the developmentally critical basement mem-
brane between endoderm and epiblast. This conclusion is-
seemingly in disagreement with the Henry and Campbell
(1998) article. In that analysis, it was reported that base-
ment membranes failed to form in dystroglycan-null EBs,
and it was therefore suggested that dystroglycan is essential
for basement membrane assembly. However, this could not
represent a general receptor requirement as was implied be-
cause knockout of the dystroglycan gene in mice is charac-
terized by a loss of Reichert’s membrane, but not a loss of
the embryonal basement membrane adjacent to epiblast
(Williamson et al., 1997). Furthermore, the skeletal muscle
of dystroglycan-deficient chimeric mice has been found to
possess basement membrane (Cote et al., 1999). Of note,
neither the wild-type nor dystroglycan-null EBs used in the
study of Henry and Campbell developed epiblast and only
1% of EBs cavitated (both central attributes of embryonic
differentiation), making unclear what step of differentiation
was modeled. Together, we conclude that dystroglycan is
not a fundamental requirement for basement membrane as-
sembly in tissues.
A striking finding in our analysis was the loss of the epi-
blast layer through apoptosis. It has previously been ob-
served that only those cells that adhere to basement mem-
brane survive to differentiate with the nonadherent cells
undergoing anoikis (Coucouvanis and Martin, 1995).
However, continued survival of the epiblast was clearly de-
pendent upon a dystroglycan interaction. This receptor de-
pendency was significantly greater than that which we ob-
served in the laminin-rescued integrin null, and a general
survival role for dystroglycan is supported by in vitro stud-
ies conducted on muscle cells (Montanaro et al., 1999).
The survival deficit seen in both receptor nulls raises the
possibility that cell adhesion strength determines survival
regardless of the specific receptor involved, and that the
observed difference in survivability is due to asymmetric
compensation in which only the integrin-null loss of recep-
tor binding is largely replaced by high cell surface expres-
sion of dystroglycan.
EBs lacking  1-laminin,  1-integrin, or functional FGF
receptors fail to express essential laminin subunits, fail to
form a basement membrane, and fail to differentiate (Li et
al., 2001, and this study). In each case, assembly and dif-
ferentiation could be rescued with exogenous laminin-1,
strongly suggesting that lack of extracellular laminin, rather
than a problem with cell surface ability to mediate assembly,
caused the defect. During development, laminin expression
became restricted to the zone underneath the endodermal
layer, the major source of laminin synthesis and secretion
(Murray and Edgar, 2001a). This step requires FGF signal-
ing and  1-integrin. Interestingly, the findings of Li et al.
(2001) argue that laminin is both necessary and sufficient to
mediate epiblast differentiation in the absence of endoderm.
Our data provide evidence for a mechanism in which lami-
nin must both polymerize through its LN domains (Yur-
chenco and Cheng, 1993) and interact with the cells of the
ICM through a heparin-binding sequence in LG4 to initiate
site-specific basement membrane assembly and to trigger
differentiation. The new findings also argue that the laminin
polymer creates the initial architectural scaffolding that must
assemble before other components can accumulate into the
ECM, and that is crucial for cellular differentiation.
Materials and methods
Culturing of embryonic stem cells and EBs 
Wild-type R1 (Smyth et al., 1999) and D3 ES cells (Doetschman et al.,
1985),  1-laminin–null (Smyth et al., 1999), and dystroglycan-null (Cote et
al., 1999) ES cells were grown on feeder layers of mitomycin-treated (10 Embryonic basement membrane assembly | Li et al. 1289
 g/ml, 2 h) SNL STO cells in ES medium (MEM  -medium; catalog No.
12463-014; Life Technologies) supplemented with 15% ES-grade FCS (Life
Technologies), 0.1 mM nonessential amino acids, 0.1 mM  -mercaptoetha-
nol, 1 mM sodium pyruvate, 100  g/ml penicillin, 100  g /ml streptomy-
cin, and 1,000 U/ml leukemia inhibitory factor (LIF; Life Technologies).  1-
Integrin–null (clone G201) ES cells (Fässler et al., 1995) were cultured
directly on Falcon tissue culture dishes (Becton Dickinson) in ES medium.
ES cells were subcultured at semi-confluence, and the medium was changed
every day to maintain the cells in an undifferentiated state. To culture EBs,
subconfluent ES cells were dispersed with 0.25% trypsin-0.53 mM EDTA
and plated onto gelatin-coated dishes for 3 h to allow feeder cells to selec-
tively attach. Nonadherent ES cell aggregates were then dispersed and cul-
tured on bacteriological petri dishes in ES medium without LIF.
Proteins and antibodies
Laminin-1 (DEAE-unbound fraction) and laminin fragments E1’ (short arm
complex), E3 ( 1-LG modules 4–5), E4 ( 1-domains VI and V), E8 (lower
coiled-coil with LG1–3), and C1–4 (polymerizing  1 1 1 short-arm com-
plex) were prepared from the mouse EHS tumor as described previously
(Yurchenco and Cheng, 1993; Yurchenco and O’Rear, 1994). Nonpolymer-
izing laminin-1 was prepared by treatment with 5 mM AEBSF in 50 mM
Tris-HCl and 90 mM NaCl, pH 7.4, in the cold overnight (Colognato et al.,
1999). AEBSF-E1’ (nonpolymerization inhibition control) was prepared by
incubation of E1’ under the same conditions followed by dialysis to remove
AEBSF. Laminin-2/4 and laminin-4 were prepared from collagenase-treated
human placenta as described previously (Cheng et al., 1997). Recombinant
laminin-5 ( 3A 3 2), produced in transfected HEK-293 cells, was a gift of
Dr. Ariel Boutaud (BioStratum Incorporated, Research Triangle Park, NC).
Reducing SDS-PAGE revealed 150-kD ( 3), 140-kD ( 2), and 105-kD ( 2)
bands. Recombinant laminin-8 ( 4 1 1) was prepared as described previ-
ously (Kortesmaa et al., 2000).
Rat monoclonal anti–laminin  1 (clone A5; Upstate Biotechnology),
rabbit anti–mouse type IV collagen antibody (Rockland Immunochemi-
cals), rat anti–mouse perlecan mAb, and rabbit anti–mouse type I collagen
antibody (CHEMICON International, Inc.) were used for immunostaining
at 1, 2.5, 2, and 2.5  g/ml respectively. Rabbit pAbs specific for laminin-1,
E4 ( 1 subunit), mouse laminin-1 RG50 ( 1 LG 4–5) fractionated from re-
combinant G-domain were prepared and characterized as described previ-
ously (Yurchenco and Ruben, 1987; Handler et al., 1997; Yurchenco et
al., 1997). E4 and RG50 antibodies were used for immunoprecipitation at
10  g/ml and EHS–laminin-1 antibody was applied on immunoblots at 3
 g/ml. Rabbit polyclonal nidogen-specific antibody was generated with
purified EHS-nidogen, affinity-purified with immobilized nidogen and
cross-absorbed with laminin, and used at 3 (immunoprecipitation) and 1
 g/ml (immunoblotting, immunofluorescence). Mouse monoclonal IgM
antibody IIH6 hybridoma medium specific for  -dystroglycan (Ervasti and
Campbell, 1991), a gift of Kevin Campbell (Howard Hughes Medical Insti-
tute, University of Iowa, Iowa City, Iowa), was used as conditioned hybrid-
oma medium at 1:2 dilution. Mouse mAb specific for  -dystroglycan (No-
vocastra Laboratories Ltd) was used at a dilution of 1:100. Rat anti–mouse
integrin  1-chain mAb (2  g/ml for immunoblotting and 5  g/ml for im-
munofluorescence), and hamster anti–mouse integrin  3-chain mAb (5  g/
ml for immunofluorescence) were obtained from BD Biosciences.
FITC- and Cy5-conjugated antibodies specific for mouse IgG, mouse
IgM, and rabbit IgG (Jackson ImmunoResearch Laboratories) were used at
1:100 dilutions. HRP-linked antibodies specific for mouse IgG, rat IgG,
and rabbit IgG (Amersham Pharmacia Biotech) were used as secondary an-
tibodies for immunoblotting at a dilution of 1:3,000.
Sample preparation
EBs were collected into 10-ml tubes and allowed to sediment by gravity.
After washing in PBS with 0.5% BSA, the EBs were fixed with 3% parafor-
maldehyde in PBS and followed by incubation in 7.5% sucrose-PBS for 3 h
at room temperature and then in 15% sucrose-PBS at 4 C overnight. The
EBs were embedded in Tissue-Tek OCT (Miles, Inc.) and 4- m-thick fro-
zen sections were prepared. Nonspecific binding sites were blocked with
5% goat serum. FITC- and/or Cy5-conjugated antibodies were used as sec-
ondary reagents and nuclei were counterstained with DAPI.
Microscopy
Slides were viewed by indirect immunofluorescence using an inverted micro-
scope (model IX70; Olympus) fitted with an IX-FLA fluorescence observation
attachment and a MicroMax 5-mHz CCD camera (Princeton Instruments)
controlled by IP Lab 3.0 (Scanalytics). EBs were allowed to settle in 15-ml
conical tubes, and then washed with PBS by resuspension/settling. The cell
pellet was fixed in 0.5% glutaraldehyde and 0.2% tannic acid in PBS for 1 h
(room temperature), washed with 0.1 M sodium cacodylate buffer, trans-
ferred to modified Karnovsky’s fixative, post-fixed in 1% osmium tetroxide for
1 h, and then dehydrated and embedded in Epon/SPURR resin (EM Science).
Thick (1  m) and thin sections ( 90 nm) were cut with a diamond knife on
an ultramicrotome. Thick sections were stained with 1% methylene blue in
1% sodium borate for light microscopy, and thin sections were stained with
saturated uranyl acetate followed by 0.2% lead citrate. Images were photo-
graphed with an electron microscope (model JEM-1200EX; JEOL USA, Inc.).
TUNEL staining. Apoptosis was assessed by terminal deoxynucleotidyl
transferase-mediated dUTP-fluorescein nick end-labeling (Promega). EB
cryosections were washed in PBS, fixed with 3% paraformaldehyde in PBS
for 30 min, and permeabilized with 0.2% Triton X-100 in PBS. DNA frag-
ments were end-labeled with 0.5 U/ml terminal transferase and 5 mM flu-
orescein 12-dUTP for 1 h at 37 C. Slides were washed twice in 2  SSC
followed by three washes in PBS. EBs were immunostained for laminin and
counterstained with DAPI.
Protein assays
Protein in solution was determined either by absorbance at 280 nm or the
Bradford assay (Bio-Rad Laboratories). SDS-PAGE was performed in 3.5–
12% linear gradient gels and electrophoretic transfer of proteins onto PVDF
membranes was performed as described previously (Yurchenco and Cheng,
1993; Cheng et al., 1997). Blots were blocked with 5% nonfat dried milk
and 0.2% Tween 20 in 50 mM Tris-HCl, 150 mM NaCl, pH 7.4, and then
incubated with primary antibody followed by antibody-HRP. Reacting
bands were detected by ECL (Amersham Biosciences). Immunoprecipitation
(IP) was performed at 4 C with the addition of protease inhibitor cocktails
(Sigma-Aldrich) to all the protein samples and buffers. EB-conditioned me-
dium or lysates were precleared with 20  l of 50% protein A–agarose (pAb
IP) or protein G–Sepharose bead slurry (mAb IP). Samples were incubated
with antibody overnight and precipitated with 40  l protein A–agarose or
protein G–Sepharose beads for 2 h and followed by washing in 50 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 1% NP-40, and 0.1% SDS. After an additional
wash, the supernatant was removed and the immunoprecipitates were ana-
lyzed by SDS-PAGE. Duplicates of type IV collagen antibody immunopre-
cipitates were incubated with 5 U bacterial collagenase (CLSPA; Worthing-
ton Biochemical Corporation) at 37 C for 1 h. After collagenase digestion,
the immunoprecipitates were washed twice in PBS and analyzed.
Semi-quantitative RT-PCR
Total RNA was isolated with TRIzol
® reagent (Life Technologies) and re-
verse-transcribed to cDNA using SuperScript™ II reverse transcriptase (Life
Technologies). The primers and PCR annealing conditions for brachyury,
BMP4, low molecular weight NFL,  -globulin, and hypoxanthine guanine
phosphoribosyl transferase (HPRT) were described previously (Levinson-
Dushnik and Benvenisty, 1997; Rohwedel et al., 1998; Weinhold et al.,
2000). PCR products were electrophoretically resolved on 2% agarose gels.
Production of recombinant E3 and its mutant
Laminin- 1LG4–5 was amplified by PCR from a mouse laminin  1 chain
cDNA. BM40 signal sequence and a FLAG epitope were introduced into
the 5 -end of the cDNA fragment. The heparin/dystroglycan-binding site
KRK in LG4 was replaced with AAA via PCR-based mutagenesis as de-
scribed previously (Andac et al., 1999). Both wild-type and KRK mutant
were cloned into mammalian expression vector pcDNA3.1/Zeo  (Invitro-
gen) and the sequence of the inserts was confirmed by automated se-
quencing. The constructs were expressed in HEK 293 cells and stable
clones expressing wild-type or the mutant E3 were selected with Zeocin™.
Recombinant LG4–5 proteins were purified to homogeneity by FLAG affin-
ity chromatography (Yurchenco et al., 1997).
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